<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Liver transplantation: Anesthetic management
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Liver transplantation: Anesthetic management
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Liver transplantation: Anesthetic management
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gebhard Wagener, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael F O'Connor, MD, FCCM
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 14, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1752848256">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         This topic will discuss anesthetic management during liver transplantation, including postoperative pain management.
        </p>
        <p>
         The preanesthetic consultation and preparations for liver transplantation are discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2531599938">
         <span class="h1">
          PRE-INCISION MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H4286596942">
         <span class="h2">
          Intravascular access
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reliable large bore venous access is necessary for administration of intravenous (IV) fluids, blood products, and vasopressors. Rapid transfusion devices are nearly always employed since massive blood loss is possible during various phases of liver transplantation surgery (see
         <a class="local">
          'Specific considerations for each surgical phase'
         </a>
         below). We typically insert a central venous catheter (CVC) into an internal jugular vein after induction of general anesthesia but before surgical incision. We use ultrasound guidance, which reduces risk of hematoma in patients with coagulopathy, and detects thrombi in the internal jugular vein in those with hypercoagulability. (See
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Disorders of coagulation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6315.html" rel="external">
          "Basic principles of ultrasound-guided venous access"
         </a>
         .)
        </p>
        <p>
         In many centers, a second peripheral large-bore rapid infusion catheter is also inserted [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2872025046">
         <span class="h2">
          Monitoring considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative monitoring practice patterns in liver transplant centers have been assessed by the Liver Transplant Anesthesia Consortium, and are reflected in the recommendations below [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiovascular monitoring
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Intra-arterial monitoring
         </strong>
         – We typically place a radial arterial catheter in the right or left wrist (depending on planned intraoperative positioning of the patient) before induction of anesthesia, although many centers place this catheter shortly after induction (see
         <a class="local">
          'Induction of general anesthesia'
         </a>
         below). A second arterial catheter is placed in the femoral artery or the opposite radial artery as back-up in most centers, in case the first catheter fails [
         <a href="#rid1">
          1,2
         </a>
         ]. Generally, a femoral artery is preferred for the second site because femoral arterial blood pressure (BP) measurements are typically more reliable than those from the smaller radial arterial site, particularly during infusion of high vasopressor doses. In some instances, retraction of the rib cage to obtain adequate surgical visualization can compress the subclavian artery against the first rib; in such cases the femoral arterial pressure can be 10 to 20 mmHg higher than the radial arterial pressure for the duration of the retraction [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8174.html" rel="external">
          "Intra-arterial catheterization for invasive monitoring: Indications, insertion techniques, and interpretation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Central venous catheter
         </strong>
         – As noted above, a CVC is typically inserted into an internal jugular vein (see
         <a class="local">
          'Intravascular access'
         </a>
         above), and one port is used to monitor central venous pressure (CVP). Although not a reliable indicator of intravascular volume status, continuous measurement of CVP allows recognition of directional changes. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Traditional static parameters'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pulmonary artery catheter
         </strong>
         – A pulmonary artery catheter is still routinely used in most centers for liver transplant patients to monitor cardiac output (CO), pulmonary artery pressure, and increases in pulmonary vascular resistance (PVR) [
         <a href="#rid1">
          1,2
         </a>
         ]. We employ a pulmonary artery catheter with capabilities to measure continuous CO and mixed venous oxygen saturation (SVO
         <sub>
          2
         </sub>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Patients in liver failure have a baseline vasodilatory state compensated by elevated CO to preserve perfusion of vital organs (see
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Cardiopulmonary changes'
         </a>
         ). Thus, it is important to detect any decrease in CO since this may portend cardiovascular collapse (eg, sudden deterioration of right ventricular [RV] function due to sudden increases in PVR). Notably, continuous CO values may not be reliable during large volume resuscitation; however, SVO
         <sub>
          2
         </sub>
         measurements generally remain accurate. (See
         <a class="medical medical_review" href="/z/d/html/1595.html" rel="external">
          "Pulmonary artery catheterization: Interpretation of hemodynamic values and waveforms in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Transesophageal echocardiography
         </strong>
         – Transesophageal echocardiography (TEE) is often used to monitor hemodynamics and to diagnose causes of hemodynamic instability (eg, exacerbation of preexisting conditions or new adverse events) [
         <a href="#rid4">
          4-21
         </a>
         ]. Specific examples that may cause sudden severe hypotension include [
         <a href="#rid7">
          7-9,16,20,22-33
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Hypovolemia due to sudden reductions in preload due to bleeding or inferior vena cava (IVC) manipulation
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Low systemic vascular resistance (SVR) refractory to vasopressors due to liver failure, cirrhotic cardiomyopathy or post-reperfusion syndrome (see
         <a class="local">
          'Post-reperfusion syndrome'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Myocardial systolic dysfunction due to cirrhotic cardiomyopathy (with relative volume overload)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Diastolic dysfunction due to cirrhotic cardiomyopathy
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         RV distention and failure caused by acute changes in filling pressures due to rapidly occurring volume shifts or changes in PVR after release of toxic metabolites or pulmonary emboli
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Cardiac tamponade
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Severe myocardial ischemia
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Thromboembolic phenomena including air emboli or formation of thrombi in the LV, RV, or IVC, due to a pre-existing prothrombotic state in end-stage liver disease, as well as air or thrombotic pulmonary emboli (see
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Disorders of coagulation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Intra-cardiac thrombosis
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Presence of stenosis of the hepatic vein or IVC
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         A nasogastric tube is typically inserted gently before TEE probe insertion to empty the stomach, and also improve visibility within the surgical field by reducing gastric distention. Many liver transplant recipients have esophageal varices and higher risk (see
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Esophageal pathology'
         </a>
         ). We employ extra lubrication for the nasogastric tube and the TEE probe, with careful gentle insertion to minimize this risk. (See
         <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">
          "Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Contraindications and precautions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other cardiovascular monitors
         </strong>
         – Other devices to assess CO and intravascular volume status are used in some liver transplant centers [
         <a href="#rid34">
          34-37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/107337.html" rel="external">
          "Novel tools for hemodynamic monitoring in critically ill patients with shock", section on 'Cardiac output'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/107337.html" rel="external">
          "Novel tools for hemodynamic monitoring in critically ill patients with shock", section on 'Volume tolerance and fluid responsiveness'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neuromonitoring
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Intracranial pressure monitoring
         </strong>
         – In selected patients with severe encephalopathy and elevated intracranial pressure, invasive intracranial pressure monitoring may have been established in the preoperative period to optimize cerebral perfusion. If present, this monitoring is continued throughout the transplantation including the neohepatic phase [
         <a href="#rid38">
          38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Acute liver failure with increased intracranial pressure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cerebral oximetry
         </strong>
         – Although neuromonitoring with cerebral oximetry using near-infrared spectroscopy is not common, some centers use this technology to recognize impaired cerebral autoregulation and track cerebral deoxygenation during the anhepatic phase, as well as hyperoxygenation during the reperfusion phase [
         <a href="#rid38">
          38,39
         </a>
         ]. (See
         <a class="local">
          'Anhepatic phase'
         </a>
         below and
         <a class="local">
          'Reperfusion phase'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3310804619">
         <span class="h2">
          Antibiotic prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prophylactic antibiotics should be administered before the surgical incision. Selection is based on the center's routine protocols for abdominal/biliary surgery. (See
         <a class="medical medical_review" href="/z/d/html/13984.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28764283">
         <span class="h2">
          Induction of general anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         We induce general anesthesia after placement of an intra-arterial catheter to continuously monitor BP. For patients with inadequate time for fasting and those with increased intra-abdominal pressure due to moderate or severe ascites, rapid sequence anesthetic induction and endotracheal intubation is typically employed with appropriate additional precautions against aspiration.
         <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">
          Succinylcholine
         </a>
         can be used as a rapid-acting neuromuscular blocking agent (NMBA) during rapid sequence induction and intubation in patients without hyperkalemia. Although a non-depolarizing NMBA that is not metabolized by the liver (eg,
         <a class="drug drug_general" data-topicid="9270" href="/z/d/drug information/9270.html" rel="external">
          cisatracurium
         </a>
         ) is an alternative, slower onset of action is not optimal for rapid sequence induction and intubation. (See
         <a class="medical medical_review" href="/z/d/html/94214.html" rel="external">
          "Rapid sequence induction and intubation (RSII) for anesthesia"
         </a>
         .)
        </p>
        <p>
         Many clinicians select
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         for anesthetic induction in patients without severe comorbidities. However, propofol doses are typically decreased, and coadministration of vasopressor drugs is often necessary to maintain hemodynamic stability. In patients with end-stage liver disease, BP and CO are maintained by activation of the sympathetic system to compensate for chronically low SVR (see
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Cardiopulmonary changes'
         </a>
         ). Since this sympathetic drive is decreased by induction of general anesthesia, severe hypotension may occur. Alternatively, induction with
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         or
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         or a narcotic-based induction may be used for patients when hemodynamic instability is of particular concern. (See
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94536.html" rel="external">
          "Perioperative uses of intravenous opioids in adults: General considerations", section on 'High-dose opioid induction technique'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H485132065">
         <span class="h1">
          MANAGEMENT DURING THE TRANSPLANTATION PROCEDURE
         </span>
        </p>
        <p class="headingAnchor" id="H2960439642">
         <span class="h2">
          Maintenance of general anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Either inhalation or intravenous (IV) agents may be employed to maintain general anesthesia during liver transplantation.
        </p>
        <p>
        </p>
        <p>
         Compared with patients with normal liver function, patients with end-stage liver disease require a lower minimum alveolar concentration (MAC) of a potent inhalation anesthetic to prevent motor responses to initial skin incision (eg, for
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         , approximately 1.3 percent compared with 1.7 percent) [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         Total intravenous anesthesia (TIVA) has also been used for maintenance of general anesthesia during liver transplantation, particularly if the aim is to achieve tracheal extubation in the operating room immediately after transplantation [
         <a href="#rid41">
          41
         </a>
         ].
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          Propofol
         </a>
         is typically selected as the primary agent for maintenance of a TIVA technique. Despite a larger volume of distribution, propofol dosing need not be significantly adjusted for patients with liver disease; however, recovery from propofol is typically delayed due to greater sensitivity to its pharmacodynamic effects [
         <a href="#rid42">
          42
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/91242.html" rel="external">
          "Anesthesia for the patient with liver disease", section on 'Sedative hypnotics'
         </a>
         ). Although a continuous infusion of
         <a class="drug drug_general" data-topicid="9270" href="/z/d/drug information/9270.html" rel="external">
          cisatracurium
         </a>
         is often selected (see
         <a class="medical medical_review" href="/z/d/html/91242.html" rel="external">
          "Anesthesia for the patient with liver disease", section on 'Neuromuscular blocking agents'
         </a>
         ), higher doses are typically required and recovery may be prolonged, possibly due to increased extracellular fluid and increased volume of distribution in patients with end-stage liver disease compared with those with normal liver function [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3737490970">
         <span class="h2">
          Hemodynamic and vasopressor management
         </span>
         <span class="headingEndMark">
          —
         </span>
         We maintain a mean arterial pressure (MAP) ≥65 to 75 mmHg throughout all phases of liver transplant procedures. A higher target may be selected for patients with preexisting hypertension. Most patients require vasopressor therapy in various phases of the transplant procedure to maintain adequate MAP due to the chronic vasodilatory state associated with end-stage liver disease, the superimposed vasodilatory effects of general anesthetic agents, as well as preload and afterload changes and severe metabolic abnormalities during various phases of the surgical procedure. (See
         <a class="local">
          'Specific considerations for each surgical phase'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Cardiopulmonary changes'
         </a>
         .)
        </p>
        <p>
         There is no general consensus regarding choice of vasopressors  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid44">
          44
         </a>
         ]. We routinely administer
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         2 to 10 mcg/minute (0.03 to 0.15 mcg/kg per minute), and add
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         0.01 to 0.04 units/minute to compensate for endogenous vasopressin deficiency if the patient is hypotensive and vasodilated during any stage of the liver transplant. Vasopressin also beneficially reduces portal hypertension by decreasing portal venous flow and pressure and increasing hepatic arterial flow [
         <a href="#rid45">
          45,46
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          Dobutamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9384" href="/z/d/drug information/9384.html" rel="external">
          dopamine
         </a>
         , and/or
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         may be added to provide inotropic support when appropriate. For example, we occasionally add an epinephrine infusion during the anhepatic phase and/or after reperfusion if blood pressure (BP) remains marginal despite high dose of both
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         (eg, &gt;15 mcg/minute) and
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         (eg, &gt;0.1 units/min).
        </p>
        <p class="headingAnchor" id="H238135215">
         <span class="h2">
          Blood and coagulation management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transfusions of red blood cells (RBCs) and other blood products (eg, fresh frozen plasma [FFP] or prothrombin complex concentrate [PCC]; cryoprecipitate or
         <a class="drug drug_general" data-topicid="9082" href="/z/d/drug information/9082.html" rel="external">
          fibrinogen concentrate
         </a>
         ; or platelets)
         <strong>
         </strong>
         are usually necessary during liver transplantation. Information rapidly derived from intraoperative laboratory testing for anemia and for coagulopathy allows rational decision-making regarding transfusion of RBCs and other blood components. (See
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Intraoperative diagnostic testing'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H424620668">
         <span class="h3">
          Management of anemia
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Blood salvage
         </strong>
         – To avoid or minimize allogeneic blood transfusion, most liver transplantation centers employ intraoperative blood salvage using a cell saver system to separate, wash, and concentrate salvaged red blood cells (RBCs) for reinfusion in most patients [
         <a href="#rid1">
          1,2
         </a>
         ]. Contraindications include presence of cancer (hepatocellular carcinoma), localized infection, or otherwise contaminated surgical field. Suctioning of ascites, bile, and intestinal content into the cell saver system is avoided. (See
         <a class="medical medical_review" href="/z/d/html/7937.html" rel="external">
          "Surgical blood conservation: Intraoperative blood salvage"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Notably, there are no coagulation factors in cell saver blood because plasma is washed away and replaced with 0.9%
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         ; thus, dilutional coagulopathy may occur. Since salvaged blood does not contain any significant amount of potassium after the washing process, it can be transfused even if severe hyperkalemia is present, and is preferred rather than transfusion of allogeneic RBCs from the blood bank. Another option is washing of fresh blood with the cell saver before transfusion into a hyperkalemic patient.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Red blood cell transfusion
         </strong>
         – Transfusion of RBCs and other blood products is usually necessary during liver transplantation surgery, although surgery without transfusion has become more common with use of strategies such as intraoperative blood salvage and antifibrinolytic administration [
         <a href="#rid47">
          47
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94347.html" rel="external">
          "Perioperative blood management: Strategies to minimize transfusions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A sufficient reserve of blood products should be immediately available in or near the operating room. Use of a rapid transfusion system is often necessary. (See
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Red blood cells'
         </a>
         and
         <a class="local">
          'Pre-anhepatic (dissection) phase'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Decisions to transfuse salvaged or allogeneic blood are guided by balancing risks of transfusion with risks of anemia. We use point-of-care (POC) instruments to measure hemoglobin (Hb) for earlier detection of anemia, although these measurements are not as accurate as standard laboratory measurements [
         <a href="#rid48">
          48-52
         </a>
         ]. Typically, the selected Hgb transfusion trigger is &lt;7 to 8 g/dL. However, factors that may necessitate a more liberal transfusion trigger (Hb &lt;9 g/dL) include severity of ongoing and anticipated blood loss and current intravascular volume status. For example, severe bleeding often occurs in the pre-anhepatic phase during surgical dissection of the diseased liver, particularly if the patient has portal hypertension and coagulopathy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Allogeneic RBCs from the blood bank contain potassium; the concentration increases with age of the RBCs and can be &gt;50 mmol/L [
         <a href="#rid53">
          53
         </a>
         ]. During transfusion of large volume transfusion of RBCs, moderate (&gt;5.5 mEq/L) or severe (&gt;6.5 mEq/L) hyperkalemia may occur. Further transfusion of allogeneic RBC units is stopped until treatment of hyperkalemia has been initiated and lower potassium levels have been confirmed [
         <a href="#rid54">
          54
         </a>
         ]. In some patients, the transplant team may elect to order "prewashing," of some blood bank RBC units to lower their potassium content, or perform intraoperative washing of fresh blood in the cell saver unit. Such washed units are kept in reserve until severe bleeding and hyperkalemia occurs (see
         <a class="local">
          'Hyperkalemia and other metabolic abnormalities'
         </a>
         below). Risk for postoperative acute kidney injury may also be increased after transfusion of older RBCs stored for &gt;14 days, possibly due to accumulated proinflammatory substances [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H478584439">
         <span class="h3">
          Management of coagulopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Coagulation defects in liver disease are complex and may cause profound bleeding diathesis or hypercoagulability with consequent risk of thrombosis [
         <a href="#rid56">
          56,57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Disorders of coagulation'
         </a>
         .)
        </p>
        <p>
         Preoperative coagulopathy is present in many patients with end-stage liver disease. Accelerated fibrinolysis may result in rapid dissolution of clots after formation, thereby contributing to coagulopathy [
         <a href="#rid58">
          58-61
         </a>
         ]. In addition, marginal donor organ quality (for example with a donation after cardiac death donor) may cause a delay in function of the newly grafted liver, which may delay resolution of coagulopathy during the neohepatic phase. (See
         <a class="local">
          'Neohepatic phase'
         </a>
         below and
         <a class="local">
          'Persistent bleeding'
         </a>
         below.)
        </p>
        <p>
         Correction of coagulopathy and blood management are further complicated by the complex derangements of the coagulation system that may also lead to hypercoagulability. For example, thrombosis of a tenuous hepatic artery anastomosis may occur more readily if coagulopathy is aggressively corrected, especially if platelets are transfused. (See
         <a class="local">
          'Thromboembolism'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Coagulation testing
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Standard laboratory tests of coagulation
         </strong>
         – Standard coagulation tests include prothrombin time, activated partial thromboplastin time, international normalized ratio (INR), and platelet count (see
         <a class="medical medical_review" href="/z/d/html/1368.html" rel="external">
          "Clinical use of coagulation tests"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4433.html" rel="external">
          "Platelet function testing"
         </a>
         ). However, these standard tests may not detect hypercoagulability since they only measure the ability of pro-coagulant cascades to form thrombin (patients with liver disease can have normal or even increased thrombin generation [
         <a href="#rid57">
          57,62-64
         </a>
         ]). However, these standard tests do not assess factors affecting firm clot formation after initial thrombin formation, or factors contributing to clot strength (eg, fibrinogen concentration, platelet function) [
         <a href="#rid57">
          57,65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Viscoelastic tests
         </strong>
         – Viscoelastic POC tests of coagulation, such as thromboelastography (TEG) or an adaptation of TEG known as rotational thromboelastometry (ROTEM), are used in many centers to test overall hemostatic function in liver transplantation and other selected procedures (eg, cardiac or trauma surgery) [
         <a href="#rid57">
          57,66-70
         </a>
         ]. A TEG or ROTEM tracing provides information regarding clot initiation (ie, initial thrombin formation), kinetics of ongoing clot formation, eventual clot strength, and clot dissolution via fibrinolysis  (
         <a class="graphic graphic_figure graphicRef100078" href="/z/d/graphic/100078.html" rel="external">
          figure 1
         </a>
         ). The table provides guidance for transfusion of specific blood products during liver transplantation surgery based on TEG or ROTEM values  (
         <a class="graphic graphic_table graphicRef121036" href="/z/d/graphic/121036.html" rel="external">
          table 2
         </a>
         ), although decisions also depend on results of standard tests of coagulation, presence of ongoing bleeding, and stage of surgery [
         <a href="#rid67">
          67
         </a>
         ]. Although use of viscoelastic test guidance can reduce transfusions of blood products and specifically FFP during liver transplantation, the effect on outcomes is unclear [
         <a href="#rid57">
          57,69-72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Further information is provided in separate topics. (See
         <a class="medical medical_review" href="/z/d/html/4433.html" rel="external">
          "Platelet function testing", section on 'Viscoelastic testing (TEG and ROTEM)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Intraoperative diagnostic testing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transfusion of blood components
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Fresh frozen plasma or prothrombin complex concentrate
         </strong>
         – During the dissection phase (see
         <a class="local">
          'Pre-anhepatic (dissection) phase'
         </a>
         below), severe preexisting coagulopathy should be corrected [
         <a href="#rid56">
          56,57
         </a>
         ], primarily with the coagulation factors I, II, V, VIII, IX, X, XI, XIII, as well as anticoagulant protein C, protein S, and antithrombin III that are all contained in FFP. Furthermore, FFP is a component of massive transfusion protocols during periods of significant bleeding. However, FFP contains only a small amount of fibrinogen. (See
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Plasma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7931.html" rel="external">
          "Massive blood transfusion", section on 'Approach to volume and blood replacement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         FFP should not be transfused based on an elevated INR in the absence of clinical bleeding. Risk of over-transfusion with high volumes of FFP include transfusion-associated acute lung injury (TRALI) and thrombotic complications. Viscoelastic testing can help guide transfusion of FFP  (
         <a class="graphic graphic_table graphicRef121036" href="/z/d/graphic/121036.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid57">
          57,67,69,70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         A 4-factor PCC may be administered instead of or in addition to FFP, with selection of a product that contains FII, FVII, FIX, FX as procoagulant factors, as well as the anticoagulant factors protein C, protein S, antithrombin III, and a small amount of heparin to decrease risk for excessive thrombin generation  (
         <a class="graphic graphic_table graphicRef94210" href="/z/d/graphic/94210.html" rel="external">
          table 3
         </a>
         ). Advantages of PCCs over FFP include rapid administration of a small volume, with avoidance of volume overload or transfusion reactions (see
         <a class="medical medical_review" href="/z/d/html/7925.html" rel="external">
          "Plasma derivatives and recombinant DNA-produced coagulation factors", section on 'PCCs'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Prothrombin complex concentrates (PCCs)'
         </a>
         ) [
         <a href="#rid73">
          73-80
         </a>
         ]. Its disadvantage is that PCC are missing small amounts of other clotting proteins that FFP contains.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cryoprecipitate or
         </strong>
         <a class="drug drug_general" data-topicid="9082" href="/z/d/drug information/9082.html" rel="external">
          fibrinogen concentrate
         </a>
         <strong>
         </strong>
         – Fibrinogen concentrate or cryoprecipitate is used to treat hypofibrinogenemia (measured low fibrinogen concentration &lt;150 to 200 mg/dL), or when fibrinogen cannot be measured in a timely fashion as the patient develops clinically significant bleeding [
         <a href="#rid67">
          67,81
         </a>
         ]. . Viscoelastic testing can help guide the decision to treat hypofibrinogenemia  (
         <a class="graphic graphic_table graphicRef121036" href="/z/d/graphic/121036.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid67">
          67,69
         </a>
         ]. Low fibrinogen concentration may occur after reperfusion since the ischemic liver graft releases tissue plasminogen activator (tPA) that is washed into the circulation during reperfusion causing ongoing fibrinolysis [
         <a href="#rid82">
          82
         </a>
         ]. (See
         <a class="local">
          'Reperfusion phase'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Since fibrinogen concentrates do not contain FVIII, vWF, and FXIII, these products may have less risk of inducing hypercoagulability than cryoprecipitate [
         <a href="#rid83">
          83
         </a>
         ]. However, cryoprecipitate, which contains FVIII, von Willebrand factor (vWF), FXIII, and fibrinogen, may be used if
         <a class="drug drug_general" data-topicid="9082" href="/z/d/drug information/9082.html" rel="external">
          fibrinogen concentrate
         </a>
         is not available. (See
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Cryoprecipitate or fibrinogen concentrate'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Fibrinogen concentrate'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Platelets
         </strong>
         – We typically hold platelet transfusion until the hepatic artery anastomosis has been completed, and typically avoid such transfusion if the anastomosis is precarious even if platelet count is low. Administration of platelets is an independent predictor of worse outcome after liver transplantation [
         <a href="#rid84">
          84
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Platelet transfusion can usually be avoided during the dissection phase of liver transplantation surgery, even in patients with severe thrombocytopenia, because platelet function is often normal. This is because vWF levels are high and ADAMTS-13 levels are low in patients with end-stage liver disease. Thus, vWF can bind to a smaller amount of activated platelets with a connection that is less likely to be cleaved by ADAMTS-13. Furthermore, platelets that are typically sequestered in the enlarged spleen of patients with portal hypertension are mobilized during bleeding.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3319126926">
         <span class="h3">
          Administration of antifibrinolytic agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         We typically administer an antifibrinolytic (either epsilon-aminocaproic acid [EACA] or
         <a class="drug drug_general" data-topicid="10011" href="/z/d/drug information/10011.html" rel="external">
          tranexamic acid
         </a>
         [TXA]) typically during the pre-anhepatic phase if there is evidence of hyperfibrinolysis on TEG or ROTEM tests, or diffuse microvascular bleeding is noted [
         <a href="#rid85">
          85,86
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94347.html" rel="external">
          "Perioperative blood management: Strategies to minimize transfusions", section on 'Antifibrinolytic agents'
         </a>
         .)
        </p>
        <p>
         There is no general consensus and data are limited regarding the utility and safety of prophylactic administration of an antifibrinolytic agent during liver transplantation (see
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Disorders of coagulation'
         </a>
         and
         <a class="local">
          'Reperfusion phase'
         </a>
         below). A 2017 propensity-matched study of patients noted that transfusions of RBC and FFP were reduced in patients receiving TXA compared with those who had no TXA exposure, with no difference in thromboembolic complications after liver transplantation [
         <a href="#rid87">
          87
         </a>
         ]. A 2016 retrospective study also noted that EACA was not associated with an increased incidence of thromboembolic complications compared with no EACA exposure [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3677738962">
         <span class="h2">
          Fluid management
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Targeting optimal fluid administration
         </strong>
         – We typically target a low to normal central venous pressure (CVP) of 7 to 10 mmHg to minimize blood loss, particularly during the dissection phase (see
         <a class="local">
          'Pre-anhepatic (dissection) phase'
         </a>
         below) [
         <a href="#rid1">
          1,2,4
         </a>
         ]. CVP generally represents the downstream hydrostatic resistance to blood flow through the liver; the higher the CVP, the more congested the liver which leads to brisk venous bleeding. Higher circulating volume (or over-transfusion) is avoided, as this may worsen bleeding and/or may cause right ventricular (RV) failure. Recognizing that CVP is not a truly reliable indicator of intravascular volume status, we follow directional changes in CVP values that typically indicate changes in portal pressure that affect bleeding. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Traditional static parameters'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         With some surgical techniques, a higher CVP may be necessary to maintain stability. For example, if complete caval clamping is employed, a CVP of 10 to 15 mmHg may be required to maintain hemodynamic stability during the anhepatic phase since a larger proportion of preload is lost compared with the piggyback technique. (See
         <a class="local">
          'Specific surgical techniques'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Some centers advocate a lower volume/lower CVP (ie, &lt;5 mmHg) strategy [
         <a href="#rid36">
          36,89-92
         </a>
         ]. However, this strategy may lead to low intravascular volume status resulting in hypotension and organ hypoperfusion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Selection of fluid type
         </strong>
         – Intraoperative fluid choices include crystalloid or colloid solutions.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Crystalloid solutions
         </strong>
         – We use a balanced electrolyte crystalloid solution as maintenance fluid, and we routinely select Plasmalyte or Normosol rather than
         <a class="drug drug_general" data-topicid="108196" href="/z/d/drug information/108196.html" rel="external">
          lactated Ringer
         </a>
         solution or 0.9%
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         solution [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         We generally avoid
         <a class="drug drug_general" data-topicid="108196" href="/z/d/drug information/108196.html" rel="external">
          lactated Ringer
         </a>
         solution since lactate accumulation may occur in patients with end-stage liver disease. We generally avoid 0.9%
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         , even in patients with hyperkalemia, due to concern for hyperchloremic acidosis. Evidence in patients undergoing kidney transplantation and other major surgical procedures suggests that administration of 0.9% saline (particularly in large volumes) is associated with hyperchloremia, metabolic acidosis, renal vasoconstriction, decreased glomerular filtration rate, and kidney injury [
         <a href="#rid94">
          94-103
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/102390.html" rel="external">
          "Anesthesia for kidney transplantation", section on 'Choosing fluids'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Crystalloid solutions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Plasmalyte has magnesium rather than calcium (as in
         <a class="drug drug_general" data-topicid="108196" href="/z/d/drug information/108196.html" rel="external">
          lactated Ringer
         </a>
         solution), and can therefore be mixed with blood products that contain citrate.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Colloid solution
         </strong>
         – We
         <strong>
         </strong>
         routinely replace known albumin losses with 5%
         <a class="drug drug_general" data-topicid="9376" href="/z/d/drug information/9376.html" rel="external">
          albumin solution
         </a>
         (eg, when a large volume of ascites fluid is drained upon entry into the peritoneal cavity) [
         <a href="#rid104">
          104
         </a>
         ]. Patients with documented coagulopathy receive FFP instead.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Data regarding benefits of 5% albumin in this setting are generally scant [
         <a href="#rid105">
          105-109
         </a>
         ], except for those with hepatorenal syndrome or spontaneous bacterial peritonitis [
         <a href="#rid110">
          110-112
         </a>
         ]. However, randomized trials have not demonstrated benefits of albumin compared with crystalloid solutions in other settings [
         <a href="#rid105">
          105,107,109
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2729559700">
         <span class="h2">
          Point-of-care laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to POC tests for Hb and viscoelastic tests of coagulation (see
         <a class="local">
          'Management of anemia'
         </a>
         above and
         <a class="local">
          'Management of coagulopathy'
         </a>
         above), we employ intraoperative POC measurements of arterial blood gases and pH, arterial lactate, electrolytes, and glucose. Frequent testing and rapid turn-around of these measurements allow detection and correction of abnormalities (eg, acidosis, hyperkalemia, hyponatremia, and hyper- or hypoglycemia) [
         <a href="#rid113">
          113,114
         </a>
         ], which may improve patient stability and graft function.
        </p>
        <p class="headingAnchor" id="H3594343117">
         <span class="h2">
          Immunosuppression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Immunosuppressive drugs should be administered during transplant per institutional protocol. In many centers, steroids are administered during the anhepatic phase so that plasma concentrations are maximal during reperfusion of the donor graft. Calcineurin inhibitors such as
         <a class="drug drug_general" data-topicid="9971" href="/z/d/drug information/9971.html" rel="external">
          tacrolimus
         </a>
         and other immunosuppressants such as
         <a class="drug drug_general" data-topicid="9670" href="/z/d/drug information/9670.html" rel="external">
          mycophenolate
         </a>
         or
         <a class="drug drug_general" data-topicid="9026" href="/z/d/drug information/9026.html" rel="external">
          azathioprine
         </a>
         are typically administered after surgery (eg, on postoperative day one). (See
         <a class="local">
          'Specific considerations for each surgical phase'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/4586.html" rel="external">
          "Liver transplantation in adults: Initial and maintenance immunosuppression"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H662207804">
         <span class="h1">
          SPECIFIC CONSIDERATIONS FOR EACH SURGICAL PHASE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The liver transplantation surgical procedure occurs in four main stages: liver dissection during the pre-anhepatic phase, followed by the anhepatic, reperfusion, and neohepatic phases  (
         <a class="graphic graphic_table graphicRef121037" href="/z/d/graphic/121037.html" rel="external">
          table 4
         </a>
         ). Each phase has unique challenges and goals. Management of fluids, transfusion of blood products, and hemodynamics differ in each stage, and must also be adjusted to accommodate individual patient- and surgery-specific factors.
        </p>
        <p class="headingAnchor" id="H943886317">
         <span class="h2">
          Pre-anhepatic (dissection) phase
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pre-anhepatic stage begins with surgical incision and includes drainage of ascites fluid and dissection of the native liver from the surrounding tissue in preparation for its removal. Surgical goals include identification of the elements of the porta hepatis fissure in the inferior surface of the liver (eg, bile duct, hepatic artery, portal vein), dissection of the posterior aspect of the liver, and isolation of the vena cava. Anesthetic goals include correction of coagulopathy and maintenance of euvolemia and systemic blood pressure (BP) during drainage of ascites fluid and liver dissection. Challenges include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluid management
         </strong>
         – Upon surgical entry into the peritoneum, drainage of a significant volume of ascites fluid may result in severe hypovolemia and hypotension. As drainage occurs, volume is administered (typically 5%
         <a class="drug drug_general" data-topicid="9376" href="/z/d/drug information/9376.html" rel="external">
          albumin solution
         </a>
         ); the alternative is administration of fresh frozen plasma (FFP) in patients with coagulopathy. Care is taken to avoid low intravascular volume status that may lead to hypotension and organ hypoperfusion. However, fluid overload (or over-transfusion) is also avoided, as this increases portal pressure and worsens bleeding from variceal veins during their dissection. (See
         <a class="local">
          'Fluid management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of blood loss
         </strong>
         – Large blood losses may be incurred during dissection around the liver, depending on the severity of coagulopathy and portal hypertension. Notably, significant bleeding may not be immediately obvious (eg, during dissection of the retrohepatic vena cava). Transfusion of red blood cells (RBCs) and other blood products to replace blood loss and correct coagulopathy is used as necessary. (See
         <a class="local">
          'Blood and coagulation management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of a vasodilatory state
         </strong>
         – Most patients require vasopressor therapy during this phase because of their chronic vasodilatory state that is typically exacerbated by administration of anesthetic agents, drainage of ascites fluid, and surgical bleeding during liver dissection. (See
         <a class="local">
          'Hemodynamic and vasopressor management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1343046933">
         <span class="h3">
          Anhepatic phase
         </span>
         <span class="headingEndMark">
          —
         </span>
         The anhepatic phase begins when the native liver is removed and ends when the new liver graft is reperfused.
        </p>
        <p>
         Anesthetic management during this phase is influenced by the recipient's cardiovascular reserve as well as the surgical technique selected (see
         <a class="local">
          'Specific surgical techniques'
         </a>
         below). Regardless of these factors. the absence of liver function and hepatic lactate clearance during the anhepatic phase will cause metabolic lactic acidosis with consequent worsening of hyperkalemia.
        </p>
        <p>
         We measure blood gas and electrolyte values approximately 15 to 20 minutes into the anhepatic phase to detect hyperkalemia and promptly treat potassium levels above 4.0 to 4.5 mEq/L with insulin/glucose. Also, the surgeon is immediately notified about hyperkalemia so that alterations in surgical technique during reperfusion that reduce risk of sudden exacerbation of hyperkalemia may be planned. Blood gas and electrolyte measurements are also repeated frequently (every 15 to 20 minutes) throughout the anhepatic phase. (See
         <a class="local">
          'Hyperkalemia and other metabolic abnormalities'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2051030442">
         <span class="h4">
          Specific surgical techniques
         </span>
         <span class="headingEndMark">
          —
         </span>
         The choice of surgical technique depends on patient-specific and donor-specific criteria, as well as surgical and institutional preferences. Studies have not demonstrated the superiority of any one technique [
         <a href="#rid115">
          115-117
         </a>
         ]. The surgeon initiates a trial of the planned surgical technique to confirm hemodynamic stability before irreversible removal of the liver.
        </p>
        <p>
         The most commonly used techniques are noted below. In some cases, combinations (or variations) of these are employed:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complete caval cross-clamping technique
         </strong>
         – With this technique, the inferior vena cava (IVC) is clamped above and below the liver and commonly resected  (
         <a class="graphic graphic_figure graphicRef121038" href="/z/d/graphic/121038.html" rel="external">
          figure 2
         </a>
         ). The donor vena cava is then implanted in place of the resected recipient cava.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         This surgical technique greatly impacts recipient hemodynamics. Complete cross-clamping of the IVC results in an acute decrease in right ventricular (RV) preload, cardiac output (CO), and BP. However, administration of large volumes of fluid or blood products to compensate for this sudden loss in preload can result in a circulating volume so large that it can precipitate RV failure during reperfusion (see
         <a class="local">
          'Reperfusion phase'
         </a>
         below). In general, complete caval cross-clamping is best tolerated in patients who have extensive collateral portal circulation (varices), while the technique is poorly tolerated in those with acute liver failure or those with low Model for End-stage Liver Disease (MELD) scores (typically patients with hepatocellular cancer) (see
         <a class="medical medical_review" href="/z/d/html/1241.html" rel="external">
          "Model for End-stage Liver Disease (MELD)"
         </a>
         ). With initial clamping of the IVC, it is critically important that the surgeon and anesthesiologist jointly confirm the likelihood that a relatively stable hemodynamic profile can be maintained throughout the anhepatic phase before proceeding with final resection of the IVC and the diseased liver.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Compared with other phases of the procedure, higher doses of vasopressors such as
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         ,
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         , and possibly
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         are typically necessary during this anhepatic phase. In some cases, it is necessary to unclamp the IVC and administer additional fluids before a second attempt at caval cross-clamping is attempted.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although splanchnic and renal venous stasis also occur during this technique, there is scant evidence of clinically relevant worsening of renal function [
         <a href="#rid118">
          118
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Piggyback technique
         </strong>
         – With this technique, a partial clamp is applied to the IVC, thereby excluding the hepatic veins  (
         <a class="graphic graphic_figure graphicRef121038" href="/z/d/graphic/121038.html" rel="external">
          figure 2
         </a>
         ), rather than completely cross-clamping the IVC. After resection of the native liver, the donor IVC is sewn on top of the recipient IVC. By avoiding complete caval cross-clamping with these techniques, partial caval blood flow is present and preserves some preload to the right heart throughout the anhepatic phase such that lower volumes of fluid administration are necessary (see
         <a class="local">
          'Fluid management'
         </a>
         above). Several variations of the piggyback technique have been developed (eg, end-to-side cavocaval anastomosis or direct anastomosis of donor hepatic veins with the recipient cava. Although these techniques theoretically allow renal venous drainage throughout the anhepatic phase, there is scant evidence for potential benefit (eg, amelioration of renal injury) [
         <a href="#rid117">
          117
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Temporary portocaval bypass technique
         </strong>
         – A modification of the piggyback technique is use of a temporary portocaval shunt that drains splanchnic blood into the IVC during the anhepatic phase. Advantages include greater preservation of preload and prevention of excessive engorgement of the bowel compared with use of a piggyback technique without a portocaval shunt. Thus, hemodynamic stability is improved, particularly in patients with severe portal hypertension and/or cardiac comorbidities. However, this modification is not necessary or beneficial in all patients. Disadvantages include a longer duration of surgical time, and potential for complications of the anastomosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Venovenous bypass technique
         </strong>
         – Venovenous (VV) bypass may be instituted before removal of the liver to compensate for loss of preload during either full or partial clamping of the IVC  (
         <a class="graphic graphic_figure graphicRef121039" href="/z/d/graphic/121039.html" rel="external">
          figure 3
         </a>
         ). VV bypass drains blood from the femoral veins and portal vein back into the circulation, either through a cannula inserted into an axillary vein (accessed by cut-down) or via a transcutaneous internal jugular approach guided by transesophageal echocardiography (TEE) [
         <a href="#rid119">
          119
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Advantages of the VV bypass approach include maintenance of excellent hemodynamic stability. Also, it can be used in combination with any other surgical technique (eg, piggyback or caval replacement). Thus, this technique is often selected for patients with severe cardiovascular comorbidities. Disadvantages include increased risk for complications involving venous access (eg, vascular injury, seroma, lymphocele, venous air or thrombotic emboli), increased blood loss, and prolongation of surgical time. For these reasons, most centers no longer routinely employ VV bypass, and the technique has been replaced almost entirely by variations of the piggyback technique, as explained above [
         <a href="#rid120">
          120
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H401032155">
         <span class="h4">
          Preparation for reperfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         In preparation for reperfusion of the donor liver, blood gases and electrolytes should be checked and hyperkalemia is aggressively treated. Ideally a potassium level under 4.0 to 4.5 mEq/L should be achieved prior to reperfusion to minimize potential for severe hyperkalemia and cardiac arrest. (See
         <a class="local">
          'Hyperkalemia and other metabolic abnormalities'
         </a>
         below.)
        </p>
        <p>
         Also, we routinely administer 2 g
         <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">
          magnesium sulfate
         </a>
         (for its membrane-stabilizing and antidysrhythmic effect) [
         <a href="#rid121">
          121
         </a>
         ] as an infusion over approximately 10 to 25 minutes during the anhepatic phase in preparation for reperfusion. In one trial, patients receiving 25 mg/kg of magnesium sulfate before reperfusion had lower post-reperfusion arterial lactate levels than those receiving no magnesium [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3943081430">
         <span class="h3">
          Reperfusion phase
         </span>
         <span class="headingEndMark">
          —
         </span>
         The reperfusion phase of the donor liver begins with release of the IVC clamp, with sequential reperfusion of the portal vein occurring before or after the hepatic artery.
        </p>
        <p>
         First, the IVC cross-clamp is released, thereby providing the right heart with increased preload. Typically, BP is increased. However, significant bleeding or a kink at the caval anastomosis site may result in inadequate right heart filling and persistent hypotension.
        </p>
        <p>
         The portal vein clamp is then released and the donor graft is reperfused. Hypotension as well as pulmonary vasoconstriction may occur due to release of acid byproducts of metabolism, cytokines [
         <a href="#rid123">
          123
         </a>
         ], endotoxins [
         <a href="#rid124">
          124
         </a>
         ], and inflammatory mediators [
         <a href="#rid125">
          125
         </a>
         ], as well as activation of complement cascades [
         <a href="#rid123">
          123
         </a>
         ]. RV dysfunction may occur at this stage due to the sudden increase in preload, pulmonary artery pressure, and RV afterload [
         <a href="#rid126">
          126
         </a>
         ]. This combination of factors may lead to post-reperfusion syndrome.
        </p>
        <p>
         If the liver has been previously flushed with portal blood to prevent excessive hyperkalemia (see
         <a class="local">
          'Hyperkalemia and other metabolic abnormalities'
         </a>
         below), the portal vein may be briefly opened while the IVC is still cross-clamped and part of the caval anastomosis is still open. This maneuver can result in significant blood loss; hence, the anesthesiologist should be ready to administer fluid and/or blood. (See
         <a class="local">
          'Blood and coagulation management'
         </a>
         above.)
        </p>
        <p>
         Most surgeons complete the caval anastomoses, then reperfuse the portal vein first at the beginning of the reperfusion phase, then complete re-anastomosis of the hepatic artery to reperfuse the donor liver with oxygenated arterial blood. However, some centers delay portal vein reperfusion until the hepatic artery anastomosis has been completed so that adequate oxygen delivery to the new liver is ensured. Once anastomosed, acceptable hepatic arterial flow can be confirmed with a Doppler flow meter [
         <a href="#rid127">
          127
         </a>
         ].
        </p>
        <p>
         After adequate reperfusion, donor graft liver function is usually re-established. Intraoperative problems with vasodilation and high vasopressor requirements, acidosis and high lactate levels, and coagulopathy and bleeding will generally resolve if donor liver perfusion and function are adequate. However, coagulopathy may persist due to hyperfibrinolysis even if graft function is good. In part, this occurs because of chronic hyperfibrinolysis with decreased hepatic clearance of tissue plasminogen activator (tPA) [
         <a href="#rid58">
          58-60
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Disorders of coagulation'
         </a>
         ). Also, accumulation of tPA in the endothelium of the donor liver during the anhepatic phase is then washed into the recipient circulation during reperfusion to worsen hyperfibrinolysis [
         <a href="#rid61">
          61,128
         </a>
         ]. Thus, administration of
         <a class="drug drug_general" data-topicid="9082" href="/z/d/drug information/9082.html" rel="external">
          fibrinogen concentrate
         </a>
         or cryoprecipitate is often necessary. (See
         <a class="local">
          'Blood and coagulation management'
         </a>
         above.)
        </p>
        <p>
         Some patients experience post-reperfusion syndrome - defined as a decrease in mean arterial pressure [MAP] &gt;30 percent, occurring within five minutes of reperfusion and lasting longer than one minute. Management is described below. (See
         <a class="local">
          'Post-reperfusion syndrome'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2378195411">
         <span class="h3">
          Neohepatic phase
         </span>
         <span class="headingEndMark">
          —
         </span>
         The neohepatic phase begins after the donor liver has been reperfused and continues until the end of the procedure. Stable hemodynamics must be maintained while biliary reconstruction is performed, fastidious surgical hemostasis is achieved, and the abdominal wound is closed. Typically, lactate levels and vasopressor requirements will decrease and hemodynamic stability is present if perfusion and function of the grafted donor are adequate.
        </p>
        <p>
         Planning for timing of tracheal extubation is necessary as the procedure is being completed. (See
         <a class="local">
          'Early extubation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H190882177">
         <span class="h1">
          MANAGEMENT OF INTRAOPERATIVE COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complications that may occur during and after the reperfusion and neohepatic phases include post-reperfusion syndrome, cardiac arrest, thromboembolism, or persistent delayed graft function.
        </p>
        <p class="headingAnchor" id="H1133984865">
         <span class="h2">
          Post-reperfusion syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Post-reperfusion syndrome with a decrease of more than 30 percent in mean arterial pressure (MAP) that occurs within five minutes of reperfusion occurs in 25 to 50 percent of patients undergoing liver transplantation [
         <a href="#rid22">
          22,129-133
         </a>
         ]. The pulmonary vascular resistance (PVR), pulmonary arterial pressure, and central venous pressure (CVP) increase leading to right ventricular (RV) failure, while systemic vascular resistance (SVR) decreases [
         <a href="#rid4">
          4,22,134,135
         </a>
         ]. In addition to hemodynamic instability, post-reperfusion syndrome may be associated with electrolyte, metabolic, and coagulation abnormalities [
         <a href="#rid22">
          22
         </a>
         ]. Arrhythmias and sudden cardiovascular collapse may occur due to marked hyperkalemia and acidosis. (See
         <a class="local">
          'Cardiac arrest'
         </a>
         below.)
        </p>
        <p>
         Increasing MAP with continuous vasopressor infusions (typically
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         and
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         ), with additional intermittent boluses of
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         80 to 120 mcg or
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         10 mcg as needed may prevent development of post-reperfusion syndrome by increasing MAP [
         <a href="#rid136">
          136
         </a>
         ]. Prophylactic administration of
         <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">
          atropine
         </a>
         or
         <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">
          methylene blue
         </a>
         has little effect [
         <a href="#rid137">
          137,138
         </a>
         ].
        </p>
        <p>
         Rapid aggressive treatment is necessary for these manifestations of post-reperfusion syndrome:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe hyperkalemia, recognized by peak T-waves in the ECG (see
         <a class="medical medical_review" href="/z/d/html/2342.html" rel="external">
          "Clinical manifestations of hyperkalemia in adults", section on 'ECG changes'
         </a>
         ), and usually accompanied by severe acidosis, is particularly likely in patients with post-reperfusion syndrome. Treatment is described below. (See
         <a class="local">
          'Hyperkalemia and other metabolic abnormalities'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe hypotension is usually associated with markedly increased CVP and pulmonary artery pressure with decreased heart rate, resulting in right heart failure [
         <a href="#rid22">
          22
         </a>
         ]. Treatment includes boluses of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         and
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         , in addition to continuing infusion of higher doses of
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         (and often
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         )  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 1
         </a>
         ). If hemodynamic stability is not rapidly achieved, the surgeon can reclamp the portal vein.
        </p>
        <p>
        </p>
        <p>
         Post-reperfusion syndrome is associated with cardiac arrest, postoperative renal failure, and decreased 15-day survival [
         <a href="#rid129">
          129-133,139
         </a>
         ]. It occurs more commonly in patients who did not have a portocaval shunt, or if there is a prolonged duration of cold ischemia time, marginal donor graft, or organ size mismatch.
        </p>
        <p class="headingAnchor" id="H384298246">
         <span class="h2">
          Hyperkalemia and other metabolic abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although preoperative electrolyte abnormalities are common in patients with end-stage liver disease and are typically corrected during the dissection phase of liver transplantation, exacerbations may occur at any stage of the procedure.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyperkalemia
         </strong>
         – Severe exacerbations of hyperkalemia are particularly common during reperfusion, and must be aggressively treated:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Any potassium level above 4.5 to 5.0 mEq/L is treated with insulin (and dextrose depending on glucose levels),
         <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">
          furosemide
         </a>
         , and calcium. (See
         <a class="medical medical_review" href="/z/d/html/102390.html" rel="external">
          "Anesthesia for kidney transplantation", section on 'Management of hyperkalemia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Calcium is typically generously administered in patients requiring massive transfusion to compensate for hypocalcemia caused by the citrate anticoagulant in fresh frozen plasma (FFP) and red blood cell (RBC) transfusions (see
         <a class="medical medical_review" href="/z/d/html/7931.html" rel="external">
          "Massive blood transfusion", section on 'Hypocalcemia from citrate toxicity'
         </a>
         ) [
         <a href="#rid140">
          140
         </a>
         ]. Either
         <a class="drug drug_general" data-topicid="9186" href="/z/d/drug information/9186.html" rel="external">
          calcium chloride
         </a>
         or
         <a class="drug drug_general" data-topicid="9190" href="/z/d/drug information/9190.html" rel="external">
          calcium gluconate
         </a>
         may be administered since these agents have similar pharmacokinetic profiles (even in the absence of liver function) [
         <a href="#rid141">
          141
         </a>
         ]. Calcium chloride should be given through a central venous catheter (CVC) to minimize risk of tissue necrosis if extravasation occurs.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Washing RBCs as part of the blood salvage process removes potassium. (See
         <a class="medical medical_review" href="/z/d/html/7937.html" rel="external">
          "Surgical blood conservation: Intraoperative blood salvage"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The surgical team is immediately notified if hyperkalemia is present. In such cases, the team may elect to leave the caval anastomosis unfinished after completion of the portal anastomosis, so that the donor graft can be flushed (by temporarily unclamping the portal vein and draining the blood into the field through the hole in the caval anastomosis). This reduces the risk of potentially catastrophic hyperkalemia during reperfusion. Advance planning is necessary to carry out these maneuvers. (See
         <a class="local">
          'Specific surgical techniques'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In rare cases, intraoperative continuous renal replacement therapy (CRRT) may be necessary to treat hyperkalemia. However, CRRT is a very slow and inefficient way to remove potassium. (See
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Use of continuous renal replacement therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acidosis
         </strong>
         – Severe acidosis may also be present during reperfusion due to acid load entering the systemic circulation after release of the portal vein cross-clamp, as well as increased arterial partial pressure of carbon dioxide (PaCO
         <sub>
          2
         </sub>
         ) [
         <a href="#rid22">
          22
         </a>
         ].
         <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">
          Sodium bicarbonate
         </a>
         1 to 2 mEq/kg may be administered (in incremental intravenous [IV] boluses or as an infusion over 5 to 10 minutes) to treat severe metabolic acidosis (ie, pH &lt;7.1 and serum bicarbonate ≤6 mEq/L) that would otherwise limit the effectiveness of vasopressor and inotropic support [
         <a href="#rid142">
          142
         </a>
         ]. The dose is repeated after 30 minutes if pH remains &lt;7.1. Notably, administration of sodium bicarbonate may cause a shift of the oxyhemoglobin curve to the left with worsening of reperfusion injury [
         <a href="#rid143">
          143,144
         </a>
         ]. Also, administration of bicarbonate may cause overly rapid correction of hyponatremia, as noted below.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyponatremia
         </strong>
         – Hyponatremia is common in liver failure patients with cirrhosis, particularly if marked ascites is present (see
         <a class="medical medical_review" href="/z/d/html/2326.html" rel="external">
          "Hyponatremia in patients with cirrhosis"
         </a>
         ). Too rapid correction of hyponatremia is avoided, as this is associated with risk for neurologic complications and pontine myelinolysis. Correction may be too rapid when:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         FFP is administered in high volumes, since FFP contains a high concentration of sodium.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">
          Sodium bicarbonate
         </a>
         is administered in doses greater than 1 to 2 mEq/kg bolus, as suggested above. Alternative buffers that do not contain sodium are available (eg,
         <a class="drug drug_general" data-topicid="10027" href="/z/d/drug information/10027.html" rel="external">
          tromethamine
         </a>
         [THAM]).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         CRRT is employed. To avoid rapid correction of hyponatremia during CRRT, it may be necessary in rare cases to add dextrose to the dialysate fluid to lower its sodium concentration or add an IV infusion of D5W. Most dialysate fluids contain 140 mEq/L of sodium, and the blood concentration will rapidly equilibrate with this dialysate. (See
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Use of continuous renal replacement therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyperglycemia or hypoglycemia
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hyperglycemia
         </strong>
         – Although precise target glucose values have not been established, we typically treat hyperglycemia with a continuous infusion of
         <a class="drug drug_general" data-topicid="9030" href="/z/d/drug information/9030.html" rel="external">
          regular insulin
         </a>
         if blood glucose is &gt;180 mg/dL (see
         <a class="medical medical_review" href="/z/d/html/1753.html" rel="external">
          "Perioperative management of blood glucose in adults with diabetes mellitus", section on 'IV insulin infusion'
         </a>
         ). Hyperglycemia is common during liver transplantation due to administration of steroids for immunosuppression and the use of catecholamine vasoactive agents. (See
         <a class="local">
          'Immunosuppression'
         </a>
         above and
         <a class="local">
          'Hemodynamic and vasopressor management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hypoglycemia
         </strong>
         – Hypoglycemia is readily treated with
         <a class="drug drug_general" data-topicid="8711" href="/z/d/drug information/8711.html" rel="external">
          iv dextrose
         </a>
         if it occurs. However, since hypoglycemia is a late sign of acute liver failure, it is rare during liver transplantation [
         <a href="#rid145">
          145
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1753.html" rel="external">
          "Perioperative management of blood glucose in adults with diabetes mellitus", section on 'Avoidance of hypoglycemia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H371037320">
         <span class="h2">
          Thromboembolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Liver disease causes an imbalance of pro- and anticoagulant factors that may result in hypercoagulability with thromboembolism and coagulopathy with bleeding, either alone or concomitant. (see
         <a class="medical medical_review" href="/z/d/html/131317.html" rel="external">
          "Liver transplantation: Preanesthetic consultation and preparations", section on 'Disorders of coagulation'
         </a>
         ). If a thrombus is detected, treatment depends on its size, location, and consequent hemodynamic effects. Large symptomatic thromboembolic complication are potentially fatal, and are typically treated with tissue-type plasminogen activator (tPA) [
         <a href="#rid146">
          146,147
         </a>
         ]. Successful treatment of smaller emboli may be achieved with a heparin bolus [
         <a href="#rid148">
          148
         </a>
         ].
        </p>
        <p>
         If pulmonary or intracardiac thromboembolus is suspected, the diagnosis should be rapidly confirmed with transesophageal echocardiography (TEE) [
         <a href="#rid9">
          9,23,33
         </a>
         ]. A "flat-line," thromboelastogram (TEG) occurring within five minutes of initiating reperfusion predicts pulmonary thromboembolic complications  (
         <a class="graphic graphic_figure graphicRef100078" href="/z/d/graphic/100078.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid149">
          149
         </a>
         ]. Such a "flat-line," TEG probably indicates profound hyperfibrinolysis, either due to disseminated intravascular coagulation or formation of large venous clots that consume fibrin.
        </p>
        <p class="headingAnchor" id="H2846735046">
         <span class="h2">
          Cardiac arrest
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cardiac arrest may occur at any time during liver transplantation, but is most common shortly after reperfusion (see
         <a class="local">
          'Reperfusion phase'
         </a>
         above). Cardiopulmonary resuscitation (CPR) should commence immediately, either by direct cardiac massage through an incision in the diaphragm or with external chest compressions (see
         <a class="medical medical_review" href="/z/d/html/118690.html" rel="external">
          "Intraoperative advanced cardiac life support (ACLS)", section on 'Initial resuscitation'
         </a>
         ) [
         <a href="#rid150">
          150
         </a>
         ]. Potential causes are quickly assessed and treated (see
         <a class="local">
          'Hyperkalemia and other metabolic abnormalities'
         </a>
         above and
         <a class="local">
          'Thromboembolism'
         </a>
         above). If adequate CPR does not result in return of sustained spontaneous circulation, then venoarterial extracorporeal membrane oxygenation (VA ECMO) may be initiated to restore perfusion and allow time for recovery [
         <a href="#rid151">
          151
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/131002.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)"
         </a>
         .)
        </p>
        <p>
         In a single-center retrospective study of 1238 patients, 5.5 percent suffered intraoperative cardiac arrest, with 90 percent occurring during the neohepatic phase in patients with post-reperfusion syndrome [
         <a href="#rid129">
          129
         </a>
         ]. The most common direct causes of cardiac arrest were hyperkalemia and pulmonary thromboembolism.
        </p>
        <p class="headingAnchor" id="H2347124746">
         <span class="h1">
          CONSIDERATIONS IN THE IMMEDIATE POSTOPERATIVE PERIOD
         </span>
        </p>
        <p class="headingAnchor" id="H2675839468">
         <span class="h2">
          Early extubation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Immediate extubation in the operating room, or early extubation a few hours after surgery, has become more common for hemodynamically stable patients [
         <a href="#rid152">
          152,153
         </a>
         ]. However, early extubation is not suitable for all liver transplant recipients. Examples include those with severe preoperative comorbidities, intraoperative complications, concerns regarding poor graft quality, or persistent bleeding that may require early (&lt;36 hours) re-exploration. (See
         <a class="local">
          'Management of intraoperative complications'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H465783453">
         <span class="h2">
          Postoperative pain management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Optimal postoperative pain management is required, as in any major abdominal surgical procedure. The right subcostal incision is often most painful. We typically administer systemic opioids with a patient-controlled analgesia technique.
        </p>
        <p>
         Some centers also administer nonopioid analgesics such as
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">
          clonidine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         , and nonsteroidal antiinflammatory drugs (NSAIDs) to reduce opioid requirements [
         <a href="#rid4">
          4,154
         </a>
         ]. A few use thoracic epidural analgesia in patients without severe coagulopathy [
         <a href="#rid155">
          155
         </a>
         ], or a subcostal transversus abdominis plane [
         <a href="#rid156">
          156
         </a>
         ], or erector spinae block. (See
         <a class="medical medical_review" href="/z/d/html/118479.html" rel="external">
          "Continuous epidural analgesia for postoperative pain: Technique and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/122399.html" rel="external">
          "Transversus abdominis plane (TAP) blocks procedure guide"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/138905.html" rel="external">
          "Erector spinae plane block procedure guide"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2338180989">
         <span class="h2">
          Early postoperative complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to the intraoperative complications described above (see
         <a class="local">
          'Management of intraoperative complications'
         </a>
         above), problems that may occur in the early postoperative period include persistent bleeding or graft dysfunction.
        </p>
        <p class="headingAnchor" id="H1136762914">
         <span class="h3">
          Persistent bleeding
         </span>
         <span class="headingEndMark">
          —
         </span>
         Persistent bleeding due to persistent coagulopathy may occur at the end of surgery as a result of early graft dysfunction, or less commonly due to inadequate surgical hemostasis. Viscoelastic testing may be used to differentiate between these causes and guide transfusion of coagulation factors  (
         <a class="graphic graphic_figure graphicRef100078" href="/z/d/graphic/100078.html" rel="external">
          figure 1
         </a>
         ) (see
         <a class="local">
          'Management of coagulopathy'
         </a>
         above). If bleeding persists after transfusion of a large volume of blood products, the surgical team may elect to pack the abdomen with surgical sponges and close the wound. Once coagulopathy has been corrected, the patient can return to the operating room (typically within 24 hours) for removal of the packing and completion of any additional surgical procedures. This "damage control," approach has been used in approximately 8 percent of liver transplantation cases, and can be initiated either before or after completion of the biliary anastomosis [
         <a href="#rid157">
          157,158
         </a>
         ]. In these reports, intermediate- and long-term graft and patient survival was comparable to patients who did not need such a damage control approach.
        </p>
        <p class="headingAnchor" id="H3723616589">
         <span class="h3">
          Persistent delayed graft function
         </span>
         <span class="headingEndMark">
          —
         </span>
         Persistent delayed graft dysfunction or worsening graft failure manifests as increasing levels of arterial lactate [
         <a href="#rid127">
          127
         </a>
         ], and worsening coagulopathy within a short time after reperfusion. These early signs of donor graft dysfunction necessitate prompt rapid evaluation for correctable causes such as complications of the hepatic artery (or portal vein) anastomosis or low cardiac output (CO) state with decreased hepatic arterial perfusion. In rare cases of a nonfunctioning donor graft, relisting the patient for repeat transplantation offers the best chance for survival [
         <a href="#rid159">
          159
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3697013095">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113977.html" rel="external">
          "Society guideline links: Liver transplantation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3300095594">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reliable large bore venous access is necessary for administration of intravenous (IV) fluids, blood products, and vasopressors. We typically insert a central venous catheter (CVC) into an internal jugular vein before surgical incision. In many centers, an additional peripheral large-bore rapid infusion catheter is also inserted. (See
         <a class="local">
          'Intravascular access'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiovascular monitoring routinely includes two intra-arterial catheters, CVC to monitor central venous pressure (CVP), pulmonary artery catheter to monitor cardiac output (CO) and pulmonary artery pressure (PAP), as well as transesophageal echocardiography (TEE) to monitor hemodynamics and to diagnose causes of hemodynamic instability. (See
         <a class="local">
          'Monitoring considerations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid sequence anesthetic induction and endotracheal intubation is usually employed because of inadequate time for fasting and/or increased intra-abdominal pressure due to moderate or severe ascites. Administration of vasopressors to maintain hemodynamic stability is typically necessary during induction. Either inhalation or IV agents may be used to maintain general anesthesia. (See
         <a class="local">
          'Induction of general anesthesia'
         </a>
         above and
         <a class="local">
          'Maintenance of general anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We maintain mean arterial pressure (MAP) ≥65 to 75 mmHg throughout all phases of liver transplant procedures. A higher target may be selected for patients with preexisting hypertension. Most patients require vasopressor therapy such as
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         (and additionally
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         ) during various phases of the transplant procedure to maintain the target MAP  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Hemodynamic and vasopressor management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transfusions of red blood cells (RBCs) and other blood products including fresh frozen plasma (FFP) or prothrombin complex concentrate (PCC), cryoprecipitate or
         <a class="drug drug_general" data-topicid="9082" href="/z/d/drug information/9082.html" rel="external">
          fibrinogen concentrate
         </a>
         , and platelets
         <strong>
         </strong>
         are usually necessary during liver transplantation surgery. Intraoperative blood salvage using a cell saver system is typically employed to avoid or minimize allogeneic RBC transfusion. Intraoperative point-of care (POC) testing for anemia and coagulopathy allows for rational decision-making regarding transfusions. (See
         <a class="local">
          'Blood and coagulation management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We suggest a low to normal CVP target of 7 to 10 mmHg (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). We suggest administration of the balanced electrolyte crystalloid solution Plasmalyte or Normosol as maintenance fluid (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). We
         <strong>
         </strong>
         replace known albumin losses (eg, when a large volume of ascites fluid is drained upon entering the peritoneal cavity) with 5%
         <a class="drug drug_general" data-topicid="9376" href="/z/d/drug information/9376.html" rel="external">
          albumin solution
         </a>
         . Patients with documented coagulopathy receive FFP instead. (See
         <a class="local">
          'Fluid management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intraoperative POC laboratory testing includes measurement of arterial blood gases and pH, arterial lactate, electrolytes, and glucose. Frequent testing and rapid turn-around of these measurements allow detection and correction of abnormalities (eg, hyperkalemia, acidosis, hyponatremia, hypoglycemia, hyperglycemia). (See
         <a class="local">
          'Point-of-care laboratory testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Specific considerations for each phase of the liver transplantation procedure are noted above (see
         <a class="local">
          'Specific considerations for each surgical phase'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The pre-anhepatic stage includes the initial incision, drainage of ascites, and surgical dissection of the native liver in preparation for its removal. (See
         <a class="local">
          'Pre-anhepatic (dissection) phase'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The anhepatic phase begins when the native liver is removed and ends when the new graft is reperfused. The surgeon initiates a trial of the selected surgical technique to confirm hemodynamic stability before irreversibly removing the liver. (See
         <a class="local">
          'Anhepatic phase'
         </a>
         above and
         <a class="local">
          'Specific surgical techniques'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In preparation for reperfusion of the donor liver, blood gases and electrolytes should be checked and hyperkalemia is aggressively treated. We suggest administration of 2 g
         <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">
          magnesium sulfate
         </a>
         as an infusion over approximately 10 to 25 minutes in preparation for reperfusion (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Anhepatic phase'
         </a>
         above and
         <a class="local">
          'Preparation for reperfusion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The reperfusion phase of the donor liver begins with release of the IVC clamp, with sequential reperfusion of the portal vein and hepatic artery. (See
         <a class="local">
          'Reperfusion phase'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The neohepatic phase begins after the donor liver has been reperfused, and includes biliary reconstruction, fastidious surgical hemostasis, closure or the abdominal wound, and planning for tracheal extubation. If perfusion and function of the grafted donor are adequate, lactate levels and vasopressor requirements will decrease. (See
         <a class="local">
          'Neohepatic phase'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe intraoperative complications requiring rapid treatment may occur. These include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Post-reperfusion syndrome (a decrease in MAP &gt;30 percent, occurring within five minutes of reperfusion and lasting longer than one minute) may result in right heart failure, or severe hypotension or hyperkalemia. (See
         <a class="local">
          'Post-reperfusion syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe exacerbations of hyperkalemia and acidosis are particularly likely during reperfusion and must be aggressively treated. Other metabolic abnormalities include hyponatremia and hypoglycemia or hyperglycemia. (See
         <a class="local">
          'Hyperkalemia and other metabolic abnormalities'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diagnosis of suspected pulmonary or intracardiac thromboembolus is rapidly confirmed with TEE. Large symptomatic potentially fatal thromboembolic complications are often treated with tissue-type plasminogen activator (tPA) while a heparin bolus may adequately treat smaller emboli. (See
         <a class="local">
          'Thromboembolism'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiac arrest most commonly occurs shortly after reperfusion due to hyperkalemia or thromboembolic complications. In some cases, venoarterial extracorporeal membrane oxygenation (VA ECMO) may be initiated. (See
         <a class="local">
          'Cardiac arrest'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For postoperative pain management, we typically administer systemic opioids with a patient-controlled analgesia technique. Some centers use nonopioid analgesics such as
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">
          clonidine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         , and nonsteroidal antiinflammatory drugs (NSAIDs) or a regional anesthetic technique such as subcostal transversus abdominis plane block to reduce opioid requirements. (See
         <a class="local">
          'Postoperative pain management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative complications may include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent bleeding due to persistent coagulopathy as a result of early graft dysfunction or inadequate surgical hemostasis. Viscoelastic testing may be used to differentiate between these causes  (
         <a class="graphic graphic_figure graphicRef100078" href="/z/d/graphic/100078.html" rel="external">
          figure 1
         </a>
         ). In some cases, the abdomen is packed with sponges and the wound is closed, with planned completion of the procedure after approximately 24 hours when coagulopathy has been corrected. (See
         <a class="local">
          'Persistent bleeding'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent delayed graft dysfunction or worsening graft failure with increasing lactate levels and vasopressor requirements, and worsening coagulopathy. Correctable causes are sought (eg, complications of the portal vein or hepatic artery anastomosis, low CO state with decreased hepatic arterial perfusion). (See
         <a class="local">
          'Persistent delayed graft function'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Schumann R, Mandell MS, Mercaldo N, et al. Anesthesia for liver transplantation in United States academic centers: intraoperative practice. J Clin Anesth 2013; 25:542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walia A, Mandell MS, Mercaldo N, et al. Anesthesia for liver transplantation in US academic centers: institutional structure and perioperative care. Liver Transpl 2012; 18:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dulitz MG, De Wolf AM, Wong H, et al. Compression of the brachial plexus during right lobe liver donation as a cause of brachial plexus injury: a case report. Liver Transpl 2005; 11:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markin NW, Ringenberg KJ, Kassel CA, et al. 2018 Clinical Update in Liver Transplantation. J Cardiothorac Vasc Anesth 2019; 33:3239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wax DB, Torres A, Scher C, Leibowitz AB. Transesophageal echocardiography utilization in high-volume liver transplantation centers in the United States. J Cardiothorac Vasc Anesth 2008; 22:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vetrugno L, Barbariol F, Baccarani U, et al. Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool. Crit Ultrasound J 2017; 9:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isaak RS, Kumar PA, Arora H. PRO: Transesophageal Echocardiography Should Be Routinely Used for All Liver Transplant Surgeries. J Cardiothorac Vasc Anesth 2017; 31:2282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vanneman MW, Dalia AA, Crowley JC, et al. A Focused Transesophageal Echocardiography Protocol for Intraoperative Management During Orthotopic Liver Transplantation. J Cardiothorac Vasc Anesth 2020; 34:1824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shillcutt SK, Ringenberg KJ, Chacon MM, et al. Liver Transplantation: Intraoperative Transesophageal Echocardiography Findings and Relationship to Major Postoperative Adverse Cardiac Events. J Cardiothorac Vasc Anesth 2016; 30:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukazawa K, Quinlan CA, Pretto EA Jr, et al. Chronic Moderate Aortic Regurgitation in Liver Transplantation: Prevalence, Perioperative Management, and Short-Term Outcomes. J Cardiothorac Vasc Anesth 2019; 33:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suriani RJ, Cutrone A, Feierman D, Konstadt S. Intraoperative transesophageal echocardiography during liver transplantation. J Cardiothorac Vasc Anesth 1996; 10:699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter TR, Shillcutt SK, Adams MS, et al. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2015; 28:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reeves ST, Finley AC, Skubas NJ, et al. Special article: basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg 2013; 117:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zardi EM, Abbate A, Zardi DM, et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010; 56:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellis JE, Lichtor JL, Feinstein SB, et al. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg 1989; 68:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steltzer H, Blazek G, Gabriel A, et al. Two-dimensional transesophageal echocardiography in early diagnosis and treatment of hemodynamic disturbances during liver transplantation. Transplant Proc 1991; 23:1957.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Costa MG, Chiarandini P, Della Rocca G. Hemodynamics during liver transplantation. Transplant Proc 2007; 39:1871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burtenshaw AJ, Isaac JL. The role of trans-oesophageal echocardiography for perioperative cardiovascular monitoring during orthotopic liver transplantation. Liver Transpl 2006; 12:1577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Wolf A. Transesophageal echocardiography and orthotopic liver transplantation: general concepts. Liver Transpl Surg 1999; 5:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Argalious M, Fares M. Pro: Dynamic LVOT Obstruction Should Be Considered an "Expected" Finding in Patients With End-Stage Liver Disease Undergoing Dobutamine Stress Echocardiography in Preparation for Liver Transplantation. J Cardiothorac Vasc Anesth 2017; 31:2290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Marchi L, Wang CJ, Skubas NJ, et al. Safety and Benefit of Transesophageal Echocardiography in Liver Transplant Surgery: A Position Paper From the Society for the Advancement of Transplant Anesthesia (SATA). Liver Transpl 2020; 26:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning MW, Kumar PA, Maheshwari K, Arora H. Post-Reperfusion Syndrome in Liver Transplantation-An Overview. J Cardiothorac Vasc Anesth 2020; 34:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gologorsky E, De Wolf AM, Scott V, et al. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl 2001; 7:783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lerner AB, Sundar E, Mahmood F, et al. Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs. Anesth Analg 2005; 101:1608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeh PA, Chen HP, Tsai YC, et al. Successful management of air embolism-induced ventricular fibrillation in orthotopic liver transplantation. Acta Anaesthesiol Taiwan 2005; 43:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prah GN, Lisman SR, Maslow AD, et al. Transesophageal echocardiography reveals an unusual cause of hemodynamic collapse during orthotopic liver transplantation--two case reports. Transplantation 1995; 59:921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma A, Pagel PS, Bhatia A. Intraoperative iatrogenic acute pericardial tamponade: use of rescue transesophageal echocardiography in a patient undergoing orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2005; 19:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glance LG, Keefe DL, Carlon GC. Left atrial thrombus following liver resection with veno-venous bypass: use of transesophageal echocardiography to guide resuscitation. J Cardiothorac Vasc Anesth 1993; 7:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feierman D. Case presentation: transesophageal echocardiography during orthotopic liver transplantation--not only a different diagnosis, but different management. Liver Transpl Surg 1999; 5:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aniskevich S, Shine TS, Feinglass NG, Stapelfeldt WH. Dynamic left ventricular outflow tract obstruction during liver transplantation: the role of transesophageal echocardiography. J Cardiothorac Vasc Anesth 2007; 21:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim YC, Doblar DD, Frenette L, et al. Intraoperative transesophageal echocardiography in orthotopic liver transplantation in a patient with hypertrophic cardiomyopathy. J Clin Anesth 1995; 7:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suriani RJ, Abel M. Acute superior vena cava syndrome resulting from inferior vena cava cross-clamping. J Cardiothorac Vasc Anesth 1997; 11:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dalia AA, Khan H, Flores AS. Intraoperative Diagnosis of Intracardiac Thrombus During Orthotopic Liver Transplantation With Transesophageal Echocardiography: A Case Series and Literature Review. Semin Cardiothorac Vasc Anesth 2017; 21:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asamoto M, Orii R, Otsuji M, et al. Reliability of cardiac output measurements using LiDCOrapid™ and FloTrac/Vigileo™ across broad ranges of cardiac output values. J Clin Monit Comput 2017; 31:709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee M, Weinberg L, Pearce B, et al. Agreement in hemodynamic monitoring during orthotopic liver transplantation: a comparison of FloTrac/Vigileo at two monitoring sites with pulmonary artery catheter thermodilution. J Clin Monit Comput 2017; 31:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fayed NA, Yassen KA, Abdulla AR. Comparison Between 2 Strategies of Fluid Management on Blood Loss and Transfusion Requirements During Liver Transplantation. J Cardiothorac Vasc Anesth 2017; 31:1741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiele RH, Bartels K, Gan TJ. Inter-device differences in monitoring for goal-directed fluid therapy. Can J Anaesth 2015; 62:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar SS, Mashour GA, Picton P. Neurologic Considerations and Complications Related to Liver Transplantation. Anesthesiology 2018; 128:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zheng Y, Villamayor AJ, Merritt W, et al. Continuous cerebral blood flow autoregulation monitoring in patients undergoing liver transplantation. Neurocrit Care 2012; 17:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baron-Stefaniak J, Götz V, Allhutter A, et al. Patients Undergoing Orthotopic Liver Transplantation Require Lower Concentrations of the Volatile Anesthetic Sevoflurane. Anesth Analg 2017; 125:783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cammu G, Decruyenaere J, Troisi R, et al. Criteria for immediate postoperative extubation in adult recipients following living-related liver transplantation with total intravenous anesthesia. J Clin Anesth 2003; 15:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Servin F, Cockshott ID, Farinotti R, et al. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 1990; 65:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cammu G, Bossuyt G, De Baerdemaeker L, et al. Dose requirements and recovery profile of an infusion of cisatracurium during liver transplantation. J Clin Anesth 2002; 14:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skytte Larsson J, Bragadottir G, Redfors B, Ricksten SE. Renal effects of norepinephrine-induced variations in mean arterial pressure after liver transplantation: A randomized cross-over trial. Acta Anaesthesiol Scand 2018; 62:1229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagener G, Kovalevskaya G, Minhaz M, et al. Vasopressin deficiency and vasodilatory state in end-stage liver disease. J Cardiothorac Vasc Anesth 2011; 25:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagener G, Gubitosa G, Renz J, et al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl 2008; 14:1664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massicotte L, Thibeault L, Roy A. Classical Notions of Coagulation Revisited in Relation with Blood Losses, Transfusion Rate for 700 Consecutive Liver Transplantations. Semin Thromb Hemost 2015; 41:538.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broderick AJ. Point-of-care haemoglobin measurement - state of the art or a bleeding nuisance? Anaesthesia 2015; 70:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barker SJ, Shander A, Ramsay MA. Continuous Noninvasive Hemoglobin Monitoring: A Measured Response to a Critical Review. Anesth Analg 2016; 122:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wittenmeier E, Lesmeister L, Pirlich N, et al. Assessment of haemoglobin measurement by several methods - blood gas analyser, capillary and venous HemoCue® , non-invasive spectrophotometry and laboratory assay - in term and preterm infants. Anaesthesia 2019; 74:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegrist KK, Rice MJ. Point-of-Care Blood Testing: The Technology Behind the Numbers. Anesth Analg 2019; 129:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herman J, Park B, Awsare B, et al. Point-of-care versus central testing of hemoglobin during large volume blood transfusion. BMC Anesthesiol 2019; 19:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olson J, Talekar M, Sachdev M, et al. Potassium changes associated with blood transfusion in pediatric patients. Am J Clin Pathol 2013; 139:800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aboudara MC, Hurst FP, Abbott KC, Perkins RM. Hyperkalemia after packed red blood cell transfusion in trauma patients. J Trauma 2008; 64:S86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Y, Li Q, Ma T, et al. Transfusion of Older Red Blood Cells Increases the Risk of Acute Kidney Injury After Orthotopic Liver Transplantation: A Propensity Score Analysis. Anesth Analg 2018; 127:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002; 22:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forkin KT, Colquhoun DA, Nemergut EC, Huffmyer JL. The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management. Anesth Analg 2018; 126:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu KQ, Yu AS, Tiyyagura L, et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 2001; 96:1581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferro D, Celestini A, Violi F. Hyperfibrinolysis in liver disease. Clin Liver Dis 2009; 13:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dzik WH, Arkin CF, Jenkins RL, Stump DC. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood 1988; 71:1090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheema SP, Webster NR, Dunn F, Bellamy MC. Mediators of fibrinolysis in orthotopic liver transplantation. Clin Transplant 1996; 10:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher C, Patel VC, Stoy SH, et al. Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure. J Crit Care 2018; 43:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Habib M, Roberts LN, Patel RK, et al. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int 2014; 34:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lisman T, Bakhtiari K, Pereboom IT, et al. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010; 52:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Townsend JC, Heard R, Powers ER, Reuben A. Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization. Am J Cardiol 2012; 110:1062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mallett SV. Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation. Semin Thromb Hemost 2015; 41:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bezinover D, Dirkmann D, Findlay J, et al. Perioperative Coagulation Management in Liver Transplant Recipients. Transplantation 2018; 102:578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas W, Samama CM, Greinacher A, et al. The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital-associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH. J Thromb Haemost 2018; 16:2336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang SC, Shieh JF, Chang KY, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010; 42:2590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakai T. Viscoelastic testing in liver transplantation. Transfusion 2020; 60 Suppl 6:S61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dias JD, Sauaia A, Achneck HE, et al. Thromboelastography-guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis. J Thromb Haemost 2019; 17:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnet A, Gilquin N, Steer N, et al. The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: A randomised controlled study. Eur J Anaesthesiol 2019; 36:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy JH, Douketis J, Steiner T, et al. Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non-vitamin K Anticoagulant Reversal. Anesthesiology 2018; 129:1171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pagano D, Milojevic M, Meesters MI, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg 2018; 53:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghadimi K, Levy JH, Welsby IJ. Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting. Anesth Analg 2016; 122:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith MM, Ashikhmina E, Brinkman NJ, Barbara DW. Perioperative Use of Coagulation Factor Concentrates in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2017; 31:1810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghadimi K, Welsby IJ. Pro: Factor Concentrates are Essential for Hemostasis in Complex Cardiac Surgery. J Cardiothorac Vasc Anesth 2018; 32:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldhammer JE, Herman CR. A Split From Conventional Blood Component Therapy? J Cardiothorac Vasc Anesth 2018; 32:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun GH, Patel V, Moreno-Duarte I, et al. Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation. J Cardiothorac Vasc Anesth 2018; 32:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatt HV, Subramaniam K. PRO: Prothrombin Complex Concentrate Should Be Used in Preference to Fresh Frozen Plasma for Hemostasis in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth 2018; 32:1062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bolliger D, Szlam F, Molinaro RJ, et al. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009; 102:793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porte RJ, Bontempo FA, Knot EA, et al. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989; 47:978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franchini M, Lippi G. Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus 2012; 10:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pereboom IT, de Boer MT, Haagsma EB, et al. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 2009; 108:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makwana J, Paranjape S, Goswami J. Antifibrinolytics in liver surgery. Indian J Anaesth 2010; 54:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy JH, Koster A, Quinones QJ, et al. Antifibrinolytic Therapy and Perioperative Considerations. Anesthesiology 2018; 128:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Badenoch A, Sharma A, Gower S, et al. The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study. Transplantation 2017; 101:1658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicolau-Raducu R, Ku TC, Ganier DR, et al. Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation. J Cardiothorac Vasc Anesth 2016; 30:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massicotte L, Carrier FM, Denault AY, et al. Development of a Predictive Model for Blood Transfusions and Bleeding During Liver Transplantation: An Observational Cohort Study. J Cardiothorac Vasc Anesth 2018; 32:1722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schroeder RA, Collins BH, Tuttle-Newhall E, et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2004; 18:438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massicotte L, Lenis S, Thibeault L, et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006; 12:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feng ZY, Xu X, Zhu SM, et al. Effects of low central venous pressure during preanhepatic phase on blood loss and liver and renal function in liver transplantation. World J Surg 2010; 34:1864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinberg L, Collins N, Van Mourik K, et al. Plasma-Lyte 148: A clinical review. World J Crit Care Med 2016; 5:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Malley CMN, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100:1518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burdett E, Dushianthan A, Bennett-Guerrero E, et al. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev 2012; 12:CD004089.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkes NJ, Woolf R, Mutch M, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gheorghe C, Dadu R, Blot C, et al. Hyperchloremic metabolic acidosis following resuscitation of shock. Chest 2010; 138:1521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sen A, Keener CM, Sileanu FE, et al. Chloride Content of Fluids Used for Large-Volume Resuscitation Is Associated With Reduced Survival. Crit Care Med 2017; 45:e146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999; 90:1265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schäfer M, Von Ungern-Sternberg BS, Wight E, Schneider MC. Isotonic fluid absorption during hysteroscopy resulting in severe hyperchloremic acidosis. Anesthesiology 2005; 103:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah RB, Shah VR, Butala BP, Parikh GP. Effect of intraoperative human albumin on early graft function in renal transplantation. Saudi J Kidney Dis Transpl 2014; 25:1148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ertmer C, Kampmeier TG, Volkert T, et al. Impact of human albumin infusion on organ function in orthotopic liver transplantation--a retrospective matched-pair analysis. Clin Transplant 2015; 29:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mukhtar A, EL Masry A, Moniem AA, et al. The impact of maintaining normal serum albumin level following living related liver transplantation: does serum albumin level affect the course? A pilot study. Transplant Proc 2007; 39:3214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           China L, Freemantle N, Forrest E, et al. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. N Engl J Med 2021; 384:808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salerno F, Navickis RJ, Wilkes MM. Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis. BMC Gastroenterol 2015; 15:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narula N, Tsoi K, Marshall JK. Should albumin be used in all patients with spontaneous bacterial peritonitis? Can J Gastroenterol 2011; 25:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong F, Pappas SC, Curry MP, et al. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. N Engl J Med 2021; 384:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapoor D, Srivastava M, Singh P. Point of care blood gases with electrolytes and lactates in adult emergencies. Int J Crit Illn Inj Sci 2014; 4:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luukkonen AA, Lehto TM, Hedberg PS, Vaskivuo TE. Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting. Clin Chem Lab Med 2016; 54:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Figueras J, Llado L, Ramos E, et al. Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study. Liver Transpl 2001; 7:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isern MR, Massarollo PC, de Carvalho EM, et al. Randomized trial comparing pulmonary alterations after conventional with venovenous bypass versus piggyback liver transplantation. Liver Transpl 2004; 10:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gurusamy KS, Pamecha V, Davidson BR. Piggy-back graft for liver transplantation. Cochrane Database Syst Rev 2011; :CD008258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khosravi MB, Jalaeian H, Lahsaee M, et al. The effect of clamping of inferior vena cava and portal vein on urine output during liver transplantation. Transplant Proc 2007; 39:1197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Planinsic RM, Nicolau-Raducu R, Caldwell JC, et al. Transesophageal echocardiography-guided placement of internal jugular percutaneous venovenous bypass cannula in orthotopic liver transplantation. Anesth Analg 2003; 97:648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fonouni H, Mehrabi A, Soleimani M, et al. The need for venovenous bypass in liver transplantation. HPB (Oxford) 2008; 10:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kolte D, Vijayaraghavan K, Khera S, et al. Role of magnesium in cardiovascular diseases. Cardiol Rev 2014; 22:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JE, Jeon JP, No HC, et al. The effects of magnesium pretreatment on reperfusion injury during living donor liver transplantation. Korean J Anesthesiol 2011; 60:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bezinover D, Kadry Z, McCullough P, et al. Release of cytokines and hemodynamic instability during the reperfusion of a liver graft. Liver Transpl 2011; 17:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanot S, Gillon MC, Lopez I, Ecoffey C. Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation. Transplantation 1995; 60:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellamy MC, Galley HF, Webster NR. Changes in inflammatory mediators during orthotopic liver transplantation. Br J Anaesth 1997; 79:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Wolf AM, Begliomini B, Gasior TA, et al. Right ventricular function during orthotopic liver transplantation. Anesth Analg 1993; 76:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pratschke S, Meimarakis G, Mayr S, et al. Arterial blood flow predicts graft survival in liver transplant patients. Liver Transpl 2011; 17:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porte RJ, Blauw E, Knot EA, et al. Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation. J Hepatol 1994; 21:592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsusaki T, Hilmi IA, Planinsic RM, et al. Cardiac arrest during adult liver transplantation: a single institution's experience with 1238 deceased donor transplants. Liver Transpl 2013; 19:1262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aggarwal S, Kang Y, Freeman JA, et al. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987; 19:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paugam-Burtz C, Kavafyan J, Merckx P, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl 2009; 15:522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayanoglu HO, Ulukaya S, Tokat Y. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc 2003; 35:1442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nanashima A, Pillay P, Crawford M, et al. Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. J Hepatobiliary Pancreat Surg 2001; 8:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siniscalchi A, Gamberini L, Laici C, et al. Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies. World J Gastroenterol 2016; 22:1551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acosta F, Reche M, Sansano T, et al. Effect of reperfusion on right ventriculoarterial coupling in liver transplantation. Transplant Proc 1999; 31:2384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ryu HG, Jung CW, Lee HC, Cho YJ. Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation. Liver Transpl 2012; 18:1430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acosta F, Sansano T, Contreras RF, et al. Atropine prophylaxis of the postreperfusion syndrome in liver transplantation. Transplant Proc 1999; 31:2377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukazawa K, Pretto EA. The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome and postoperative graft function. J Hepatobiliary Pancreat Sci 2011; 18:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tokodai K, Lannsjö C, Kjaernet F, et al. Association of post-reperfusion syndrome and ischemia-reperfusion injury with acute kidney injury after liver transplantation. Acta Anaesthesiol Scand 2020; 64:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorantes RP, Boettcher BT, Woehlck HJ. Calcium Chloride Requirement and Postreperfusion Rebound During Massive Transfusion in Liver Transplantation. J Cardiothorac Vasc Anesth 2022; 36:2400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin TJ, Kang Y, Robertson KM, et al. Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function. Anesthesiology 1990; 73:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coppola S, Caccioppola A, Froio S, Chiumello D. Sodium Bicarbonate in Different Critically Ill Conditions: From Physiology to Clinical Practice. Anesthesiology 2021; 134:774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinberg L, Broad J, Pillai P, et al. Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial. Clin Transplant 2016; 30:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bond JM, Chacon E, Herman B, Lemasters JJ. Intracellular pH and Ca2+ homeostasis in the pH paradox of reperfusion injury to neonatal rat cardiac myocytes. Am J Physiol 1993; 265:C129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mallett SV, Kang Y, Freeman JA, et al. Prognostic significance of reperfusion hyperglycemia during liver transplantation. Anesth Analg 1989; 68:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boone JD, Sherwani SS, Herborn JC, et al. The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation. Anesth Analg 2011; 112:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson D, Botea A, Gubenko Y, et al. Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis. Anesth Analg 2006; 102:724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Protin C, Bezinover D, Kadry Z, Verbeek T. Emergent Management of Intracardiac Thrombosis during Liver Transplantation. Case Rep Transplant 2016; 2016:6268370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakai T, Matsusaki T, Dai F, et al. Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors. Br J Anaesth 2012; 108:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith NK, Zerillo J, Kim SJ, et al. Intraoperative Cardiac Arrest During Adult Liver Transplantation: Incidence and Risk Factor Analysis From 7 Academic Centers in the United States. Anesth Analg 2021; 132:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tejani M, Yi SY, Eudailey KW, et al. Extracorporeal membrane oxygenation as a rescue device for postreperfusion cardiac arrest during liver transplantation. Liver Transpl 2015; 21:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandell MS, Lockrem J, Kelley SD. Immediate tracheal extubation after liver transplantation: experience of two transplant centers. Anesth Analg 1997; 84:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandell MS, Stoner TJ, Barnett R, et al. A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl 2007; 13:1557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melloul E, Hübner M, Scott M, et al. Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg 2016; 40:2425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trzebicki J, Nicinska B, Blaszczyk B, et al. Thoracic epidural analgesia in anaesthesia for liver transplantation: the 10-year experience of a single centre. Ann Transplant 2010; 15:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milan ZB, Duncan B, Rewari V, et al. Subcostal transversus abdominis plane block for postoperative analgesia in liver transplant recipients. Transplant Proc 2011; 43:2687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DiNorcia J, Lee MK, Harlander-Locke MP, et al. Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant. JAMA Surg 2015; 150:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patrono D, Romagnoli R, Tandoi F, et al. Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study. Dig Liver Dis 2016; 48:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lock JF, Schwabauer E, Martus P, et al. Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation. Liver Transpl 2010; 16:172.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 94585 Version 14.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23994704" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Anesthesia for liver transplantation in United States academic centers: intraoperative practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22407934" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Anesthesia for liver transplantation in US academic centers: institutional structure and perioperative care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15666376" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Compression of the brachial plexus during right lobe liver donation as a cause of brachial plexus injury: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30853406" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : 2018 Clinical Update in Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18834818" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Transesophageal echocardiography utilization in high-volume liver transplantation centers in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28631103" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28159521" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : PRO: Transesophageal Echocardiography Should Be Routinely Used for All Liver Transplant Surgeries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32144070" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : A Focused Transesophageal Echocardiography Protocol for Intraoperative Management During Orthotopic Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26847749" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Liver Transplantation: Intraoperative Transesophageal Echocardiography Findings and Relationship to Major Postoperative Adverse Cardiac Events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30177472" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Chronic Moderate Aortic Regurgitation in Liver Transplantation: Prevalence, Perioperative Management, and Short-Term Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8910147" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Intraoperative transesophageal echocardiography during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25559474" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23966648" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Special article: basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20688208" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Cirrhotic cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2660629" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2063445" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Two-dimensional transesophageal echocardiography in early diagnosis and treatment of hemodynamic disturbances during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17692637" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Hemodynamics during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17058248" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The role of trans-oesophageal echocardiography for perioperative cardiovascular monitoring during orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10388509" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Transesophageal echocardiography and orthotopic liver transplantation: general concepts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28778774" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Pro: Dynamic LVOT Obstruction Should Be Considered an "Expected" Finding in Patients With End-Stage Liver Disease Undergoing Dobutamine Stress Echocardiography in Preparation for Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32427417" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Safety and Benefit of Transesophageal Echocardiography in Liver Transplant Surgery: A Position Paper From the Society for the Advancement of Transplant Anesthesia (SATA).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31084991" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Post-Reperfusion Syndrome in Liver Transplantation-An Overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11552212" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16301227" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16450600" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Successful management of air embolism-induced ventricular fibrillation in orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7701596" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Transesophageal echocardiography reveals an unusual cause of hemodynamic collapse during orthotopic liver transplantation--two case reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16130066" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Intraoperative iatrogenic acute pericardial tamponade: use of rescue transesophageal echocardiography in a patient undergoing orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8431579" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Left atrial thrombus following liver resection with veno-venous bypass: use of transesophageal echocardiography to guide resuscitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10447371" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Case presentation: transesophageal echocardiography during orthotopic liver transplantation--not only a different diagnosis, but different management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17678791" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Dynamic left ventricular outflow tract obstruction during liver transplantation: the role of transesophageal echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7669317" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Intraoperative transesophageal echocardiography in orthotopic liver transplantation in a patient with hypertrophic cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9105994" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Acute superior vena cava syndrome resulting from inferior vena cava cross-clamping.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27837084" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Intraoperative Diagnosis of Intracardiac Thrombus During Orthotopic Liver Transplantation With Transesophageal Echocardiography: A Case Series and Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27300325" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Reliability of cardiac output measurements using LiDCOrapid™and FloTrac/Vigileo™across broad ranges of cardiac output values.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26884378" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Agreement in hemodynamic monitoring during orthotopic liver transplantation: a comparison of FloTrac/Vigileo at two monitoring sites with pulmonary artery catheter thermodilution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28552297" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Comparison Between 2 Strategies of Fluid Management on Blood Loss and Transfusion Requirements During Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25391734" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Inter-device differences in monitoring for goal-directed fluid therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29498949" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Neurologic Considerations and Complications Related to Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22644887" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Continuous cerebral blood flow autoregulation monitoring in patients undergoing liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28678075" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Patients Undergoing Orthotopic Liver Transplantation Require Lower Concentrations of the Volatile Anesthetic Sevoflurane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14698363" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Criteria for immediate postoperative extubation in adult recipients following living-related liver transplantation with total intravenous anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2223333" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Pharmacokinetics of propofol infusions in patients with cirrhosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11943528" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Dose requirements and recovery profile of an infusion of cisatracurium during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29896798" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Renal effects of norepinephrine-induced variations in mean arterial pressure after liver transplantation: A randomized cross-over trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21126886" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Vasopressin deficiency and vasodilatory state in end-stage liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18975276" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26080304" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Classical Notions of Coagulation Revisited in Relation with Blood Losses, Transfusion Rate for 700 Consecutive Liver Transplantations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26374281" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Point-of-care haemoglobin measurement - state of the art or a bleeding nuisance?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25746056" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Continuous Noninvasive Hemoglobin Monitoring: A Measured Response to a Critical Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30427065" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Assessment of haemoglobin measurement by several methods - blood gas analyser, capillary and venous HemoCue®, non-invasive spectrophotometry and laboratory assay - in term and preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30973383" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Point-of-Care Blood Testing: The Technology Behind the Numbers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31881989" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Point-of-care versus central testing of hemoglobin during large volume blood transfusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23690124" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Potassium changes associated with blood transfusion in pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18376177" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Hyperkalemia after packed red blood cell transfusion in trauma patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28863026" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Transfusion of Older Red Blood Cells Increases the Risk of Acute Kidney Injury After Orthotopic Liver Transplantation: A Propensity Score Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11928081" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Coagulation disorders in liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28795966" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11374703" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19150306" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Hyperfibrinolysis in liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3128347" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8652893" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Mediators of fibrinolysis in orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28843665" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24164805" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20132999" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22728001" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26049072" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29337842" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Perioperative Coagulation Management in Liver Transplant Recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30171663" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital-associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20832550" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33089935" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Viscoelastic testing in liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30947389" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Thromboelastography-guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31567574" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: A randomised controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30157037" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non-vitamin K Anticoagulant Reversal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29029100" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26983050" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838728" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Perioperative Use of Coagulation Factor Concentrates in Patients Undergoing Cardiac Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29217233" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Pro: Factor Concentrates are Essential for Hemostasis in Complex Cardiac Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29126681" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : A Split From Conventional Blood Component Therapy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29198634" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29336960" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : PRO: Prothrombin Complex Concentrate Should Be Used in Preference to Fresh Frozen Plasma for Hemostasis in Cardiac Surgical Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19420005" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2499962" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22153684" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Fibrinogen replacement therapy: a critical review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19299765" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21224964" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Antifibrinolytics in liver surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29200009" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Antifibrinolytic Therapy and Perioperative Considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28187013" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27020101" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29225154" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Development of a Predictive Model for Blood Transfusions and Bleeding During Liver Transplantation: An Observational Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15365923" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Intraoperative fluid management during orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16382461" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20372900" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Effects of low central venous pressure during preanhepatic phase on blood loss and liver and renal function in liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27896148" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Plasma-Lyte 148: A clinical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15845718" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23073953" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22470070" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23235602" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Perioperative buffered versus non-buffered fluid administration for surgery in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11574338" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21138891" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Hyperchloremic metabolic acidosis following resuscitation of shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27635770" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Chloride Content of Fluids Used for Large-Volume Resuscitation Is Associated With Reduced Survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10319771" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22580944" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte®148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15983474" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Isotonic fluid absorption during hysteroscopy resulting in severe hyperchloremic acidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25394429" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Effect of intraoperative human albumin on early graft function in renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11487482" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25382301" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Impact of human albumin infusion on organ function in orthotopic liver transplantation--a retrospective matched-pair analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15163774" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : A comparison of albumin and saline for fluid resuscitation in the intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18089356" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : The impact of maintaining normal serum albumin level following living related liver transplantation: does serum albumin level affect the course? A pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33657293" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26606982" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21876859" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Should albumin be used in all patients with spontaneous bacterial peritonitis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33657294" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25337483" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Point of care blood gases with electrolytes and lactates in adult emergencies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26457784" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11679990" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15004772" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Randomized trial comparing pulmonary alterations after conventional with venovenous bypass versus piggyback liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21249703" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Piggy-back graft for liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17524931" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : The effect of clamping of inferior vena cava and portal vein on urine output during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12933376" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Transesophageal echocardiography-guided placement of internal jugular percutaneous venovenous bypass cannula in orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18773054" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : The need for venovenous bypass in liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24896250" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Role of magnesium in cardiovascular diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21738843" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : The effects of magnesium pretreatment on reperfusion injury during living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21384515" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Release of cytokines and hemodynamic instability during the reperfusion of a liver graft.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7624932" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9389852" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Changes in inflammatory mediators during orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8452268" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Right ventricular function during orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21445927" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Arterial blood flow predicts graft survival in liver transplant patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7814807" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23960018" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Cardiac arrest during adult liver transplantation: a single institution's experience with 1238 deceased donor transplants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3303534" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19399736" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12826185" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11956908" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26819522" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10500631" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Effect of reperfusion on right ventriculoarterial coupling in liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22821620" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10500627" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Atropine prophylaxis of the postreperfusion syndrome in liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21104279" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome and postoperative graft function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32020588" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Association of post-reperfusion syndrome and ischemia-reperfusion injury with acute kidney injury after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35260323" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Calcium Chloride Requirement and Postreperfusion Rebound During Massive Transfusion in Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2360741" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33721887" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Sodium Bicarbonate in Different Critically Ill Conditions: From Physiology to Clinical Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26915026" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8338121" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Intracellular pH and Ca2+ homeostasis in the pH paradox of reperfusion injury to neonatal rat cardiac myocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2643890" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Prognostic significance of reperfusion hyperglycemia during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21127275" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16492818" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28070442" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Emergent Management of Intracardiac Thrombosis during Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22174347" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32167977" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Intraoperative Cardiac Arrest During Adult Liver Transplantation: Incidence and Risk Factor Analysis From 7 Academic Centers in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25482537" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Extracorporeal membrane oxygenation as a rescue device for postreperfusion cardiac arrest during liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9024010" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Immediate tracheal extubation after liver transplantation: experience of two transplant centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17969193" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : A multicenter evaluation of safety of early extubation in liver transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27549599" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20657517" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Thoracic epidural analgesia in anaesthesia for liver transplantation: the 10-year experience of a single centre.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21911147" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Subcostal transversus abdominis plane block for postoperative analgesia in liver transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26308380" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26725163" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20104485" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
